InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Thursday, 01/21/2021 11:57:41 AM

Thursday, January 21, 2021 11:57:41 AM

Post# of 44690
Gem apparently feels better putting money into running things at RLF. Maybe they wont force a deal like NRLXP could be. (my past thoughts)
A cold shoulder to NRX/P? Maybe they're tired of the BS and realize RLF has the patents, Is developing logistics and manufacturing NOW, etc.
Main sales are to USA, SA and some EU. What do they need the leech factor of NRX for anymore? NRX is NOT putting ANYTHING into the partnership.?. Dr JJ floff for HIS company and buddies???

From the 'Last patient out PR..."All development costs under the agreement are paid by Relief, providing NeuroRx with non dilutive development capital through drug approval"

Zyesami" Relief also holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM". Now including Inhaler?...

My past thoughts were this,
"NRXP will need to settle the ownership of RLF-100 for their deal. Lawsuits question NRXP deal for High price and no control of RLF-100"...

BUT

Why carry their ball and for WHAT?